VIDEO: Long-term dupilumab facilitated weaning OCS use

In this video, Michael E. Wechsler, MD, MMSc, presents results of a post hoc analysis that evaluated long-term maintenance of oral corticosteroid reduction with dupilumab.

Long-term treatment with dupilumab helped patients with OCS-dependent asthma wean their OCS use and also reduced exacerbations and improved lung function, Wechsler, professor of medicine at National Jewish Health in Denver, told Healio.